Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have earned a consensus recommendation of “Hold” from the twenty brokerages that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is €88.21 ($103.78).

A number of analysts have recently issued reports on the stock. UBS AG set a €68.00 ($80.00) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “sell” rating in a research note on Wednesday, May 3rd. Citigroup Inc. set a €92.00 ($108.24) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Friday, June 9th. J P Morgan Chase & Co set a €106.40 ($125.18) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Tuesday, June 13th. Berenberg Bank set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Friday, June 30th. Finally, Deutsche Bank AG set a €84.00 ($98.82) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, August 8th.

TRADEMARK VIOLATION NOTICE: This piece was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/fresenius-medical-care-ag-co-kgaa-fme-given-average-rating-of-hold-by-analysts/1492419.html.

Fresenius Medical Care AG & Co. KGaA (ETR FME) traded up 1.331% on Tuesday, reaching €79.078. 1,538 shares of the company’s stock traded hands. The firm has a market capitalization of €24.27 billion and a P/E ratio of 20.391. The stock has a 50-day moving average of €82.11 and a 200 day moving average of €81.21. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €70.82 and a 52 week high of €89.07.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.